Medtronic wins FDA clearance, CE Mark for cardiac mapping software

Go back to Medtronic wins FDA clearance, CE Mark for cardiac mapping software

Medtronic announces regulatory milestones for newest cardiac mapping and ablation software

September 30, 2026 9:01 AM EDT

FDA clearance and CE Mark for latest Affera Prism-2 Mapping Software expand cardiac mapping capabilities

CE Mark for PulseSelect ProxBox Adapter with Proximity Indicator software adds real-time tissue proximity feedback

GALWAY, Ireland, Sept. 30, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced regulatory milestones for software used with two cardiac ablation... More